Viewing StudyNCT00391118



Ignite Creation Date: 2024-05-05 @ 5:07 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00391118
Status: COMPLETED
Last Update Posted: 2020-10-19
First Post: 2006-10-19

Brief Title: Comparing Two Treatments for Ovarian Cancer Standard Chemotherapy Plus Enzastaurin or Placebo Sugar Pill
Sponsor: Eli Lilly and Company
Organization: Eli Lilly and Company

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-11
Start Date Type: None
Primary Completion Date: 2010-04
Primary Completion Date Type: ACTUAL
Completion Date: 2012-07
Completion Date Type: ACTUAL
First Submit Date: 2006-10-19
First Submit QC Date: October 19 2006
Study First Post Date: 2006-10-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-10-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2011-02-25
Disp First Submit QC Date: February 25 2011
Disp First Post Date: 2011-03-11
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2020-09-23
Last Update Post Date: 2020-10-19
Last Update Post Date Type: ACTUAL